Related Experiment Video
Updated: Dec 18, 2025
06:16
Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
3.0K
Statins for age-related macular degeneration
Peter Gehlbach1, Tianjing Li, Elham Hatef
1Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, 1550 Orleans Street, Cancer Research Building #2, Baltimore, Maryland, USA, 21231.
The Cochrane Database of Systematic Reviews
|August 5, 2016
Summary
Current research indicates that statins do not effectively prevent or delay age-related macular degeneration (AMD). More high-quality studies are needed to determine if statins play a role in AMD treatment.
Area of Science:
- Ophthalmology
- Cardiovascular Medicine
- Pharmacology
Background:
- Age-related macular degeneration (AMD) is a leading cause of vision loss in individuals over 65.
- AMD shares risk factors with atherosclerosis, suggesting potential benefits from statins.
Purpose of the Study:
- To review the effectiveness of statins in delaying AMD onset and progression.
- To compare statins against placebo, no treatment, or other interventions.
Main Methods:
- Searched multiple databases including Cochrane CENTRAL, MEDLINE, EMBASE, and PubMed.
- Included randomized controlled trials (RCTs) and quasi-randomized trials.
- Two RCTs with 144 participants met criteria, comparing simvastatin to placebo.
Main Results:
- Low-quality evidence from two trials showed no significant difference in visual acuity with simvastatin.
- Statins' effect on slowing AMD progression was uncertain (OR 0.51, 95% CI 0.23 to 1.09).
- No significant differences in adverse events were reported between statin and placebo groups.
Conclusions:
- Current evidence is insufficient to support statins for preventing or delaying AMD.
- Further high-quality research is required to establish the role of statins in AMD management.
More Related Videos
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
131
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
131
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
132
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
132
01:26Atherosclerosis III: Management
259
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
259
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.2K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
01:22iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
01:27Open Angle Glaucoma: Treatment
876
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
876